<?xml version="1.0" encoding="UTF-8"?>
<p>COVID-19 can predispose to venous and arterial thromboembolic disease as a result of excessive inflammation, hypoxia, immobilization and diffuse intravascular coagulation (
 <xref rid="B1" ref-type="bibr">1</xref>). Exact knowledge of the incidence of thrombotic complications in COVID-19 patients is important for decision making regarding the intensity of thromboprophylaxis, especially in ICU patients who are at higher risk for thrombosis.
</p>
